Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$300.57 - $336.42 $145,475 - $162,827
-484 Closed
0 $0
Q1 2022

May 16, 2022

SELL
$244.61 - $310.48 $466,471 - $592,085
-1,907 Reduced 79.76%
484 $148 Million
Q4 2021

Feb 14, 2022

BUY
$198.21 - $248.9 $228,932 - $287,479
1,155 Added 93.45%
2,391 $594 Million
Q3 2021

Nov 15, 2021

SELL
$188.42 - $208.66 $470,107 - $520,606
-2,495 Reduced 66.87%
1,236 $246 Million
Q2 2021

Aug 13, 2021

BUY
$184.89 - $202.68 $429,869 - $471,231
2,325 Added 165.36%
3,731 $714 Million
Q1 2021

May 14, 2021

SELL
$169.52 - $196.53 $505,847 - $586,445
-2,984 Reduced 67.97%
1,406 $274,000
Q4 2020

Feb 12, 2021

BUY
$143.79 - $183.66 $631,238 - $806,267
4,390 New
4,390 $764,000

Others Institutions Holding MCK

About MCKESSON CORP


  • Ticker MCK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Distribution
  • Shares Outstandng 143,730,000
  • Market Cap $90.3B
  • Description
  • McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter phar...
More about MCK
Track This Portfolio

Track Alpha Paradigm Partners, LLC Portfolio

Follow Alpha Paradigm Partners, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alpha Paradigm Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Alpha Paradigm Partners, LLC with notifications on news.